decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / PROSTATE_SPECIFIC_ANTIGEN
Subscribe or sign in to view the full article.
Article Overview
This article covers the National Coverage Determinations Manual guidance for prostate-specific antigen testing, focusing on its role in prostate cancer evaluation, follow-up, and related diagnostic context. It is relevant to coders, compliance staff, and clinicians who need to understand the coverage framework, medical necessity context, and testing limitations described in the policy. The article presents broad indications for use and limitations on repeat testing without providing coding instructions or detailed case scenarios.
Why This Topic Matters
Understanding this coverage guidance helps organizations align documentation, medical necessity review, and utilization practices with Medicare policy for prostate-specific antigen testing.
Article Sections
-
Prostate Specific Antigen
Introduces the coverage topic and describes the general clinical role of prostate-specific antigen testing in prostate cancer evaluation and follow-up.
-
Indications
Summarizes the broad clinical situations in which the test is discussed as potentially useful within the coverage policy.
-
Limitations
Outlines the policy's general constraints on repeat testing and related frequency considerations.
What You Will Learn
- The clinical setting addressed by the coverage policy
- How the article frames the test's role in diagnosis and follow-up
- What general limitations on repeat testing are discussed
- How the guidance relates to Medicare coverage review and documentation
Who Should Read This
- Medical coders
- Compliance professionals
- Billing staff
- Physicians and clinical documentation teams
- Utilization review staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com